The global market for mHealth monitoring anticipated to attain $44.5 billion by 2027, growing at a double-digit CAGR of 25.5% throughout the forecast period, driven by increasing internet usage, smartphone access and adoption of innovative technologies worldwide.
- The increased use of mobile devices has driven healthcare systems, providers, and payers to develop strategies to implement and leverage the use of mobile healthcare within the organizations and practices.
- The combination of smart mobility, social networking, cloud computing and big data analytics is driving the mobile healthcare market growth.
Mobile technology is already transforming entire healthcare ecosystem and its key stakeholders as patients, physicians, providers and payers.
- Connected health is the generation, aggregation, and dissemination of health information via mobile and wireless devices and the sharing of that information between patients and providers.
Mobile healthcare services can be categorized into two broad areas:
- Solutions across the patient pathway and healthcare systems strengthening (wellness, prevention, diagnosis, treatment and monitoring).
- Healthcare systems strengthening solutions (emergency response, healthcare practitioner support, healthcare surveillance and healthcare administration).
The global mHealth monitoring market report estimates the market size ($million 2017 to 2027), market size, growth trends and forecast (CAGR% 2021 to 2027).
The global market for mHealth diagnostic products segmented by product (blood pressure monitors, blood glucose monitors, cardiac rhythm monitors, pulse monitors, sleep apnea monitors, and multi-parameter monitors), and geography.
- Among the products, the cardiac monitors segment accounted for the largest share of the total market mHealth monitoring devices.
- These products have been in great demand and widely used in detecting cardiac abnormalities such as cardiac arrest, congestive cardiac failure, cardiac fibrillation and other cardiac malignancies.
- On the other hand, the blood glucose monitoring devices segment anticipated to witness the highest CAGR throughout the forecast period.
- Rising prevalence of diabetes, technological advancements and increasing awareness among the patient population are leading to higher demand for glucose monitors worldwide.
The global market for mobile health diagnostics research report is divided by geography North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.
- In terms of geography, the North America region dominated mHealth monitoring and diagnostic devices market, with more than 50% of the total market.
- The presence of big market players are U.S. and higher public awareness and rapid technology adoption such as 3G/4G mobile networks led to its leadership position.
- However, the Asia Pacific region expected to witness the fastest growth rate over the forecast period, in-part driven by rising incidences of chronic diseases, aging population, and economic developments.
- In addition, the increasing penetration of smart phones and tablets, rising need for reduction in healthcare expenditure and lack of availability of healthcare professionals are forecast accelerate the demand for mHealth devices in the emerging markets.
- The market for mHealth monitoring and diagnostic devices is highly fragmented and comprise of many small technology companies.
- However, with increasing market potential many big players and technology giants such as Apple, Intel, Nike and Samsung have entered this market through launch of innovative products or by means of acquisitions or collaborations.
Major competitors operating in the global mHealth monitoring market and included in this report are Bayer AG, BioTelemetry, Inc. (CardioNet, Inc.), Boston Scientific Corporation, DexCom, Inc., Dräger AG, FitBit, Inc., Fora Care, Inc., iHealth Labs, Inc., Johnson & Johnson, LifeWatch AG, Masimo Corporation, Medisana AG, Medtronic plc, Nonin Medical, Inc., Omron Healthcare, Inc., Roche Holding AG (F. Hoffmann-La Roche AG), and Withings, Inc.
- Blood Pressure Monitors
- Cardiac Monitors
- Glucose Monitors
- Multi-parameter Monitors
- Pulse Oximeters
- Sleep Apnea Monitors
- North America (U.S., Canada)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Latin America (Brazil, Mexico, Rest of LA)
- Rest of the World
- Company Profiles
- Bayer AG
- BioTelemetry, Inc. (CardioNet, Inc.)
- Boston Scientific Corporation
- DexCom, Inc.
- Dräger AG
- FitBit, Inc.
- Fora Care Inc.
- iHealth Labs, Inc.
- Johnson & Johnson
- LifeWatch AG
- Masimo Corporation
- Medisana AG
- Medtronic plc
- Nonin Medical, Inc.
- Omron Healthcare, Inc.
- Roche Holding AG (F. Hoffmann-La Roche AG)
- Withings, Inc.
To request Table of Contents and Sample Pages of this report visit: